Sirtuin Activators Enhance Cognitive Performance

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods fail to effectively enhance or prevent cognitive decline in individuals, particularly in conditions such as Alzheimer's disease, Lewy body diseases, and normal aging, where learning and memory are impaired.

Innovation Solution

Administering therapeutically effective amounts of sirtuin activators, such as compounds like resveratrol, to increase the level or activity of sirtuins like SIRT1, which can be used alone or in combination with antioxidants, to improve cognitive function and performance.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current methods are used to treat cognitive decline, then treatment is provided, but cognitive performance is not effectively enhanced or decline prevented

Engineering Contradiction:
Improveeffectiveness of cognitive treatmentVSAvoidcognitive performance
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent changes the biochemical parameter of sirtuin activity in the brain by administering sirtuin activators. This activates the sirtuin pathway, which regulates genes involved in learning and memory, thereby effectively enhancing cognitive performance and preventing cognitive decline in conditions such as Alzheimer's disease, Lewy body diseases, and normal aging.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If sirtuin activators are administered to enhance cognitive function, then cognitive performance is improved, but treatment complexity increases

Engineering Contradiction:
Improvecognitive performanceVSAvoidtreatment complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent uses sirtuin activators as intermediary compounds that mediate between the administered substance and the sirtuin pathway in the brain. These activators specifically target and activate sirtuins, which then regulate cognitive function through gene expression changes, providing a targeted approach that improves cognitive performance without requiring complex treatment protocols.

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS9241916B2Cognitive performance with sirtuin activators
Publication Date: 2016.01.26 PRESIDENT & FELLOWS OF HARVARD COLLEGE
  • US9241916B2 patent drawing
  • US9241916B2 patent drawing
  • US9241916B2 patent drawing

AI summary

Provided herein are methods and compositions for enhancing the cognitive performance of a subject in need thereof. A method may include administering to a subject an agent that increases the level of protein or activity of a sirtuin, such as SIRT1.